The effect and expression of amphiregulin, a growth factor of the EGF-system was investigated in prostate primary cell cultures and in human prostate tissue. Amphiregulin increases proliferation in primary cultures of prostate myo®bro-blasts grown in serum-free medium. Amphiregulin mRNA is expressed in high amounts in primary cell cultures of prostate myo®broblasts, ®broblasts, epithelial cells, and in samples of prostate tissue. The data are supported by Westernblotting of amphiregulin in prostate myo®broblasts. These data call for a refocus of the expression and effects of the EGF system in the prostate.
Introduction
Stromal±epithelial interactions are essential for maintaining the structural and functional integrity of the adult prostate. 1 Peptide growth factors have been suggested as paracrine mediators of these cell±cell interactions, and a number of growth factors and their receptors have been found in the prostate, including the epidermal growth factor (EGF) system. 2, 3 The EGF receptor is activated by a number of ligands, such as EGF, transforming growth factor alpha (TGFa) and amphiregulin. EGF, TGFa and the EGF receptor are expressed in adult human prostatic epithelium. 4 EGF induces proliferation in pure cultures of prostate epithelial cells. 5 The localization of both ligands and receptor of the EGF system in the epithelium has led to the impression that the EGF system mainly affects the prostate epithelium. The observation that EGF stimulates also the growth of stromal cells derived from the prostate 6 challenges this model and has led to an interest in studying the expression of other members of the EGF system in the prostate. We have focused our interest on amphiregulin. Amphiregulin is a regulator of cell proliferation, and it functions as an autocrine growth factor in cultures of both nonmalignant and malignant cells. 7±11 It has previously been characterized in prostate cancer cell lines, and is found to be positively regulated by androgens. 12 In the present paper we report expression of amphiregulin and the EGF receptor in primary cultures of prostate myo-®broblasts, ®broblasts, epithelial cells and in prostate tissue, and stimulation of the growth of prostate myo-®broblasts in primary culture by amphiregulin.
Materials and methods

Human tissues
Five samples of prostate tissue were obtained from patients undergoing radical prostatectomy for prostate cancer. The tissue was examined by a pathologist and subsequently tissue specimens were excised from nonmalignant areas. Samples of normal myometrium were kindly provided by Dr Daxenbichler and Dr Mu È ller from the department of gynaecology and obstetrics, University of Innsbruck, Austria. All samples were immediately frozen in liquid nitrogen and stored at 780 C until analysis.
Cell isolation and culture
Myo®broblast, ®broblast and epithelia cell cultures from the prostate were derived from prostate tissue obtained from patients undergoing radical prostatectomy or cystectomy. Prostate stromal cells were cultured as previously described. 13 In brief, small pieces of prostate tissue were cultured in a selective medium consisting of MCBD-131 (Sigma, MO, USA) supplemented with 15% calcium stripped and heat inactivated horse serum, 10 mM HEPES, pH 7.2, 2% penicillin±streptomycin solution (120 IU/mL, and 120 mg/mL) and 2% (v/v) MEM-EAGLE solution of nonessential amino acids (Biological Industries, Israel), 10 mg/mL of 25% iron saturated transferrin and 5 mg/mL of insulin, human recombinant from yeast (Boehringer Mannheim, Germany), 5 ng/mL of sodium selenite, 0.1 mM of oestradiol, 0.1 mM of dexamethasone (all Sigma, MO, USA), 1 ng/mL of bFGF, and 0.1 ng/mL EGF, (Biomol, Germany). These cells growing out of the tissue pieces expressed smooth muscle myosin and desmin. Cultures of passage no. 4± 11 were analysed for expression of amphiregulin mRNA.
Prostate ®broblasts were obtained from prostate tissue pieces by growth in Dulbecco's modi®ed essential medium [DMEM] (Life Technologies, Denmark), supplemented with 20% fetal calf serum (Biological Industries, Israel), 1 mM HEPES, and antibiotics. Cultures of passage no. 5±12 were analysed. Primary prostate epithelial cells were cultured as described.
14 Cultures of the second passage were analysed.
Primary cell cultures of bladder stromal cells were established from fresh bladder tissue, genital skin ®bro-blasts from fore skin and scrotal skin, and skin ®broblasts from thigh skin as described. 15 These cells were cultured in DMEM, supplemented with 10% fetal calf serum and antibiotics. Smooth muscle cells from the aorta and collagenase released human umbilical vein endothelial cells were grown as described. 16, 17 All primary cell cultures were grown to semi-con¯uence. The medium was removed and the cells were washed with ice-cold phosphate buffered saline, and harvested by scraping off the cells. The cell-suspension was collected in a vial, and centrifuged for 5 min at 1500 rpm at 4 C. After repeating the wash, the supernatant was discarded, and the pellets were frozen in liquid nitrogen, and stored at 780 C until analysis.
Determination of AR mRNA by RT-PCR
Approximately 50 mg tissue or cells from a 40 cm 2 culturē ask was used for the RNA isolation, and total RNA was isolated with the Purescript kit (Gentra systems, MI, USA) according to the instructions provided by the manufacturer. The concentration and purity of the RNA preparations were analysed by measurement of the optical densities at wavelengths of 260 and 280 nm (Shimadzu, model UV-160A). 0.8 mg of the puri®ed RNA was used for cDNA synthesis in 20 mL of a buffer containing 50 mM KCl, 100 mM Tris-HCl (pH 8.3), 5 mM MgCl 2 , 1 unit/mL RNA H ase inhibitor, 1 mM of each of the four deoxynucleotides, 2.5 mM of a 16 mer d(T) 16 oligonucleotide primer, and 2.5 units/mL reverse transcriptase (all reaction components were from Perkin Elmer, Denmark). The reaction was incubated at 42 C for 30 min, and the cDNA was employed for the duplex PCR reactions. A duplex PCR reaction coamplifying amphiregulin and b-actin speci®c PCR products was performed with 2.5 mL of cDNA in 25 mL reaction mixture containing 1.5 mM MgCl 2 , 50 mM KCl, 10 mM tris-HCl (pH 9.0), 1 mM of each of the four deoxynucleotides, 1.25 units of Taq polymerase, 12.5 pmol of each of the amphiregulin primers: amphiregulin senseprimer (5 H -TTGATACTCGGCTCAGGCC-3 H , at position 255±273), and antisense-primer (5 H -CTACTGTCAAT-CATGCTGTGA-3 H , at position (793±773), and 1.0 pmol of each of the b-actin primers (all reagents from Pharmacia Biotech, Sweden, and primers from Hobolt DNA synthesis). The PCR ampli®cation program consisted of an initial heating to 94 C for 3 min and 35 cycles with a pro®le of: 60 s at 94 C, 90 s at 62 C, and 90 s at 72 C. The reactions were incubated at 72 C for 7 min after the 35 cycles of PCR ampli®cation. A Perkin Elmer 9600 thermocycler was used for the PCR reaction. Ampli®cates were separated in 1.5% agarose gels and DNA fragments were stained by ethidium bromide. Gels were visualized by the use of the Gel Doc 1000 video gel documentation system (Bio-Rad, Copenhagen, Denmark), and the images were stored in a computer. Intensity of the individual bands was determined by the use of the Molecular Analyst software (Bio-Rad, Copenhagen, Denmark) according to manufacturers instructions.
Determination of EGF receptor protein
EGF receptor protein was determined as previously described. 18 Total protein concentration, was determined by the BCA protein assay (Pierce, IL, USA).
Proliferation assay
Primary cultures of prostate myo®broblasts in ®fth and sixth passage were used. Cells were seeded in 24 well cell culture plates (Costar, MA, USA) at a density of 5610 3 cells per well, and cultured for 24 h in a selective medium as indicated above. The cells were then washed in phosphate buffered saline, and a serum free medium consisting of MCDB 131, 0.1% bovine serum albumin, 10 mM HEPES, pH 7.2, 1% penicillin± streptomycin solution (120 IU/mL, and 120 mg/mL), 1% (v/v) MEM-EAGLE solution of nonessential amino acids, 10 mg/mL of 25% iron saturated transferrin, 2.5 mg/mL of insulin, 5 ng/mL of sodium selenite, and recombinant amphiregulin (R & D systems, MIN, USA) in concentrations ranging from 0.001 nM to 1.0 nM, was added to the cells. The medium was changed after three days, and the cells were cultured for further 24± 48 h. The number of viable cells was determined using a non radioactive cell proliferation test, EZ4U (Biomedica, Austria). Statistical analysis was performed by comparing the number of viable cells after stimulation with amphiregulin relative to the number of non stimulated cells. Mann-Whitneys two sided t-test was employed. P`0.05 was considered the limit of signi®-cance. Data are given as meanAE S.D.
Af®nity puri®cation and Western blotting of amphiregulin
Prostate myo®broblasts were cultured in 10 cm tissue culture dishes (Greiner Labortechnick, Germany) until semi-con¯uence. Cells were isolated after centrifugation, and resuspended in 3 mL of ice cold HB buffer containing 2% of Triton X-100, and Complete TM protease inhibitor (Boehringer Mannheim, Germany). After sonication, and centrifugation at 20 000 g for 40 min at 4 C, the supernatant was isolated and diluted 20 fold in Tris buffered saline solution (TBS). An anti-amphiregulin antibody, (Ab-2, Neomarkers, CA, USA) was linked to cyanogenbromide activated sepharose 4B (Pharmacia, Sweden) according to manufacturer's instruction, and 2 mL of this af®nity chromatography material was transferred to a poly-prep column (Bio-Rad, CA, USA). The diluted cell supernatant was applied to the column at a¯ow of 3 mL/ h at room temperature. The protein was eluted in 3 mL of TBS containing 0.5 M NaCl. The isolated material was precipitated by addition of 20% trichloroacetic acid, for 20 min on ice, and centrifuged at 2000 g for 20 min at 4 C. The supernatant was removed, and the pellet was washed with 2 mL of acetone. The sample was left for 10 min while kept on ice, and centrifuged at 2000 g for 20 min at 4 C. The supernatant was removed and the remaining acetone was allowed to evaporate. The precipitated protein was dissolved in 160 mL of TBS and 40 mL of Laemmli buffer with 5% mercaptoethanol. SDS PAGE was performed, using a 4±20% Tris/glycine gradient gel (Novex, CA, USA) at 130 v/50 mA for 100 min. Western blotting was performed at 300 mA for 50 min using a methanol activated PVDF membrane (pore size 0.2 mM; Novex, CA, USA). The membrane was blocked in TBS containing 0.1% Tween 20, and 5% skimmed milk powder (blocking buffer) for 1 h. The membrane was incubated overnight with anti amphiregulin antibody (Ab-2, Neomarkers) diluted 1 : 1000 in blocking buffer. After washing, the membrane was incubated with peroxidase conjugated goat anti rabbit antibody, SC-2004 (Santa Cruz Biotechnology, CA, USA) diluted 1 : 2500 in blocking buffer, at room temperature for 1 h. The membrane was washed, and developed using the ECL developing kit, and the ECL hyper®lm (both Amersham, England) according manufactures instructions.
Results
Amphiregulin expression in prostate tissue cultures and prostate tissue
By using a duplex RT-PCR ampli®cation technique expression of amphiregulin mRNA was investigated in cultured prostate cells and in prostate tissue. A DNA fragment of the house-keeping protein b-actin served as an internal control. The results shown in Figure 1 revealed independent ampli®cation of a b-actin DNA fragment and a amphiregulin DNA fragment in our duplex PCR assay. The PCR products were ampli®ed similar in the duplex or the single PCR reactions.
Amphiregulin mRNA was expressed in three out of four prostate myo®broblast cell cultures from passages 4 through 11 ( Figure 2a) . In contrast, primary cultures of stromal cells of the bladder, aorta, and myometrial tissue expressed no detectable levels of amphiregulin mRNA, even though b-actin was comparable for all the samples. Primary cultures of endothelial cells from human umbilical vein also expressed no amphiregulin mRNA, con®rming previously published data. 19 To further investigate the stromal expression of amphiregulin, we analysed cultures derived from hyperplastic prostatic tissue, and from foreskin and skin. Relative to b-actin prostate ®broblasts expressed the highest amphiregulin mRNA levels (Figure 2b ). Fibroblasts derived from foreskin and skin expressed very low but detectable amounts of amphiregulin mRNA. Four samples of prostate epithelial cells in primary culture all expressed high levels of amphiregulin mRNA (Figure 2c) .
In human prostate tissue amphiregulin mRNA was expressed in all ®ve samples, obtained from patients undergoing radical prostatectomies and cystectomies, indicating that amphiregulin was expressed in the human prostate in vivo (Figure 3 ).
Western blotting
To con®rm amphiregulin expression in stromal cells of the prostate also at the protein level we isolated amphiregulin from primary prostate myo®broblast cultures by af®nity chromatography and identi®ed it by Western blotting. As shown in Figure 4 Determination of EGF receptor
The discovery of amphiregulin expression in stromal and epithelial cells from the human prostate and in prostate tissue, led us to examine the expression of the speci®c receptor for amphiregulin in the prostate derived cells by ELISA. As shown in Table 1 , cultures of prostate myo®broblasts and ®broblasts expressed EGF receptor protein in concentrations comparable to the expression in ®broblasts derived from foreskin and skin. In the three samples of human prostate hyperplastic tissue, EGF receptor protein was present, but in concentrations considerably lower than measured in the primary cell cultures.
Cell proliferation induced by amphiregulin
Four prostate myo®broblast cell cultures isolated from four different patients were treated with increasing concentrations of amphiregulin for ®ve days. Proliferation was increased by recombinant amphiregulin in all four cultures after 96±120 h of treatment. The increase in proliferation ranged from 13±38% at 1.0 nM of recombinant amphiregulin, compared to serum free medium alone, and reached signi®cance in three out of four cultures ( Figure 5) . The myo®broblasts showed a tendency towards increased proliferation also at lower concentrations of amphiregulin, although a signi®cant increase was seen only in one out of the four cultures.
Discussion
We report amphiregulin mRNA to be expressed in cell cultures of prostate myo®broblasts, ®broblasts, and prostate epithelial cells. The expression of amphiregulin in prostate stroma is unique, since neither smooth muscle cells of the bladder, the aorta, nor myometrium express amphiregulin mRNA, and ®broblasts derived from foreskin, and skin show very low expression.
The data indicating expression of amphiregulin mRNA in prostate stromal cultures was supported by the Western blotting identifying a protein of a molecular weight of approximately 32 kDa. Amphiregulin is initially synthesized as a 252 amino acid precursor protein, and the protein identi®ed in the prostate stromal cells is therefore likely to represent this precursor form.
High amounts of EGF receptor were expressed in the prostate stromal cell cultures. The concentrations measured in the growing cell cultures were 5±9 times higher than in prostate tissue. This observation most likely relates to differences in proliferation rates between the cell cultures and prostate tissue, and previous data supports the hypothesis that expression of the EGF receptor is correlated with cell proliferation. 20 EGF and TGFa have been characterized in the prostate epithelium, and the localization has led to the impression that the EGF system mainly affects prostate epithelium. The presence of amphiregulin and EGF receptor in growing cultures of prostate stromal cells indicates a role for the EGF system also in the proliferation of the prostate stroma. This is supported by our ®nding that proliferation of prostate myo®broblasts is increased by amphiregulin.
While the majority of publications report epithelial expression of amphiregulin, a few reports dealing with embryonic and fetal tissue, describe expression of amphiregulin in the mesenchyme. 9, 21 Immature mesenchymal and ®broblastic/®bromuscular stromal nodules are a constant ®nding of benign prostatic hyperplastic tissue. Lately the morphology of prostate stromal nodules has been characterized. 22 The results support the hypothesis of`reawakenging of and recapitulation of fetal processes in benign prostate hyperplasia', by McNeal. 23 Our data indicates that amphiregulin is expressed in prostate tissue in vivo and in vitro. Combining our data with previous data on expression of the EGF system in the prostate, we suggest that the EGF system may affect the growth and homeostasis of both epithelium and stroma in the human prostate. This calls for a refocus of the EGF system in the prostate. Further investigation into the expression and effects of other EGF ligands like heparin-binding EGF, betacellulin and epiregulin in prostate cell cultures are needed to assess the function of the EGF system in the prostate, and the relation to benign prostatic hyperplasia. Figure 4 Western blotting of amphiregulin from prostate myo®broblasts. Cells were homogenized in a detergent containing buffer, and amphiregulin was concentrated through af®nity puri®cation. A 32 kDa band was identi®ed in the extract from the prostate myo®broblasts (lane 2). Recombinant amphiregulin is identi®ed as a 12 kDa band (lane 1). Lanes 1i and 2i correspond to lanes 1 and 2 except that the anti-amphiregulin antibody was preincubated with amphiregulin prior to detection in Western blotting. 
